Crossmark

Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes

Crossref DOI link: https://doi.org/10.1016/j.cmet.2017.03.018

Published Print: 2017-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Morita, Shuhei

Villalta, S. Armando

Feldman, Hannah C.

Register, Ames C.

Rosenthal, Wendy

Hoffmann-Petersen, Ingeborg T.

Mehdizadeh, Morvarid

Ghosh, Rajarshi

Wang, Likun

Colon-Negron, Kevin

Meza-Acevedo, Rosa

Backes, Bradley J.

Maly, Dustin J.

Bluestone, Jeffrey A.

Papa, Feroz R.
Funding

Funding for this research was provided by:

Lundbeckfonden

National Institutes of Health (P30 DK063720)

National Institutes of Health (RO1AI046643)

National Institutes of Health (RO1DK080955)

National Institutes of Health (RO1DK100623)

National Institutes of Health (RO1GM086858)

National Institutes of Health (T32GM008268)

Burroughs Wellcome Fund

Leona M. and Harry B. Helmsley Charitable Trust

Juvenile Diabetes Research Foundation United States of America (17-2013-513)

Juvenile Diabetes Research Foundation United States of America (2-SRA-2016-234-S-N)

Juvenile Diabetes Research Foundation United States of America (3-PDF-2015-80-A-N)
License Information

Text and Data Mining valid from 2017-04-01

Text and Data Mining valid from 2017-04-01

Version of Record valid from 2018-04-04
More Information

This article is maintained by: Elsevier

Article Title: Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes

Journal Title: Cell Metabolism

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cmet.2017.03.018

Content Type: article

Copyright: © 2017 Elsevier Inc.